Biomarkers are now the currency of precision medicine and preventive health. Choose the partner that matches your goals, whether that is advancing a clinical trial, validating a new drug, or extending ...
The EV-302 study met its dual primary endpoints of overall survival (OS) and progression-free survival (PFS), compared to chemotherapy. An Independent Data Monitoring Committee determined that OS ...
Pioneering study aims to demonstrate the robustness of personalized medication analysis and recommendations for polypharmacy patients generated by MDI Health’s novel Artificial Pharmacology ...
Healthcare apps are gaining more popularity every year, and 2023 will be no exception. Discover the possibilities you can find in developing healthcare applications and the steps you need to take to ...
The ready-to-use test integrates two previously FDA-cleared indicators – a biological indicator for confirming microbial neutralization and a chemical indicator for verifying proper sterilizer ...
The landscape of diabetes management is transforming, as continuous glucose monitoring (CGM) devices expand beyond Type 1 diabetes and into a rapidly growing Type 2 market. Changes to regulatory ...
The procedure, conducted at the King Faisal Specialist Hospital & Research Centre (KFSHRC) in Riyadh, Saudi Arabia, involved extraction of the left lobe from a living donor and fully transplanting it ...
The MR-139 3001 Phase 3 trial consisted of a randomized, placebo-controlled, double-masked prospective study, with a total of 477 patients who were randomized to receive either MR-139 or placebo, self ...
These acquisitions mark a pivotal milestone in Innovia Medical’s continued growth, reinforcing its commitment to building a globally integrated platform of specialty surgical solutions. Innovia ...
This FIH Phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics, and the signs of early efficacy (LDL-C lowing effect, and liver fat quantitative value using MRI-PDFF) of ...
Cenevo brings together leading lab management systems Labguru and Mosaic to unlock the full potential of labs and accelerate scientific discovery. Titian Software and Labguru have rebranded as Cenevo, ...
As part of the transaction, HealthMark management and existing investor Ridgemont Equity Partners will both roll meaningful ownership stakes, welcoming TA as the new lead investor. Financial terms of ...